Catherine Loustalot

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog et al. · Cancer Research · 2010 · 184 citations · Full text

Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes

Olivier Humbert, Alina Berriolo-Riedinger, Jean‐Marc Riedinger et al. · Annals of Oncology · 2012 · 109 citations

Breast Oncology, Neoadjuvant Chemotherapy, 18F-fdg Tumor Metabolism +10

Pathologic Complete Response to Trastuzumab-Based Neoadjuvant Therapy Is Related to the Level of HER-2 Amplification

Laurent Arnould, Patrick Arveux, Jérôme Couturier et al. · Clinical Cancer Research · 2007 · 106 citations · Full text

Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer

A. Dezellus, P. Barrière, Mario Campone et al. · European Journal of Cancer · 2017 · 81 citations

Hormonal Contraceptive, Breast Oncology, Medicine +10

β₃-Adrenoceptor Is the Predominant β-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy

Céline Rouget, Marc Bardou, Michelle Breuiller-Fouché et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 68 citations · Full text